Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Energy and Tech: Here’s Why Traders Are Buzzing about These Five Stocks Today

Page 1 of 2

All three indexes have opened relatively flat this morning as traders brace for the major events this month, the FOMC meeting and the informal Russia/OPEC meeting.

Among the stocks grabbing trader’s attention include iRobot Corporation (NASDAQ:IRBT), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Intel Corporation (NASDAQ:INTC), Transocean LTD (NYSE:RIG), and Seadrill Ltd (NYSE:SDRL). Let’s find out why each stock is on traders’ radars and see what the funds from our database think about them.

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).

oil, rig, gas, petroleum, platform, production, petrol, sea, ocean, thailand, asia, fuel, working, water, sky, crane, cloud, power, pollution, horizontal, environmental, drill,

curraheeshutter/Shutterstock.com

iRobot Corporation (NASDAQ:IRBT) shares are 2.3% in the green today after Needham raised its price target on the stock to $46 from $42. The Needham analyst, James Ricchiuti, is more optimistic about the company’s future after meeting with iRobot’s top executives. In particular, Ricchiuti thinks that there are many ways the Roomba manufacturer can deliver earnings surprises in its consumer segment. Needless to say, the analyst has a ‘Buy’ rating on the stock. Shares of iRobot Corporation (NASDAQ:IRBT) are near a 52-week high and have rallied by over 11% year-to-date. Willem Mesdag‘s Red Mountain Capital owned more than 1 million shares of iRobot Corporation at the end of June, down by 43% on the quarter.

Follow Irobot Corp (NASDAQ:IRBT)
Trade (NASDAQ:IRBT) Now!

Two companies that normally wouldn’t be mentioned in the same sentence, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Intel Corporation (NASDAQ:INTC) are making waves today after the two agreed to agreed to collaborate on creating a wearable health device to monitor patients’ conditions with Huntington’s disease. Although there are no FDA-approved drugs that can treat the fatal disease (Huntington’s causes nerve cells to progressively break down in the brain and leads to a decline in mental stability, motor control, and cognition), there are some approved medications that can treat some of the symptoms. Teva and Intel will deploy existing technology, such as smartphones, as well as tailor new technology such as smartwatches with special sensors and a cloud platform to processes the information, to better monitor the patients. Wearable health technology will be a growing market for both companies over the next two decades as baby boomers continue to age. Of the around 750 elite funds that we track, 55 were long Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and 57 funds had a bullish position in Intel Corporation (NASDAQ:INTC) at the end of June.

Follow Teva Pharmaceutical Inds Ltd (NYSE:TEVA)
Trade (NYSE:TEVA) Now!

Follow Intel Corp (NASDAQ:INTC)
Trade (NASDAQ:INTC) Now!

On the next page, we find out why Transocean and Seadrill are trending.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!